NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.


What does NOAC stand for, in the context of stroke prophylaxis in A-Fib?

  1. Newly Observed Anticoagulant

  2. Non-Oral Anticoagulant

  3. Novel Oral Anticoagulant

  4. Non-Operative Anticoagulation

The correct answer is: Novel Oral Anticoagulant

NOAC stands for Novel Oral Anticoagulant. This term is used to refer to a newer class of anticoagulant medications that have been developed as alternatives to traditional anticoagulants such as warfarin. NOACs include medications like dabigatran, rivaroxaban, apixaban, and edoxaban. These medications have been shown to be effective in reducing the risk of stroke in patients with atrial fibrillation (A-Fib) and have certain advantages over traditional anticoagulants, such as more predictable dosing and fewer drug interactions.